Institute Funding

The Cambridge Research Institute is directly funded by Cancer Research UK, the largest medical research charity in Europe.

Cancer Research UK provides over 75% of the Institute's annual operating costs (approximately £20 million) and capital investment, with the remainder sourced from other UK and European funding bodies, such as the UK Medical Research Council (MRC) and the European Molecular Biology Organisation (EMBO).

The charity's committed and stable funding allows the researchers in the Institute to concentrate on their science, as they encounter fewer of the common distractions that sidetrack their peers working elsewhere in the scientific and research communities.

The funding provides each group leader with fully equipped laboratory space and consumables, and long-term salary funding for between 3-6 staff, as well as running costs and support for PhD students and clinical fellows. The funding also equips, supports and develops the necessary core facilities and technologies that enable the Institute's scientists to undertake groundbreaking basic biology and clinical and translational research.

Clinical Funding

In addition to the Institute's annual budget, Cancer Research UK funding together with NHS funding to the Cambridge Biomedical Research Centre, provide roughly £4 million per annum for infrastructure within Addenbrooke's Hospital to support clinical service delivery and complementary inter-disciplinary clinical research.

This clinical funding provides support for clinical trials, tissue collection and clinical information systems, new senior clinical research appointments and clinical fellowships. This substantial amount also includes support for up to five cancer specific research teams that bridge the gap between the Institute and the clinic.